Kymera Therapeutics, Inc.
KYMR
52 insider filings · Latest: Jul 27, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 20, 2026 | Feb 20 9:28 PM | PAMELA ESPOSITO | Proposed Sale | 2,500 | $86.50 | $216.3K | — | View → |
| Jan 20, 2026 | Jan 20 11:30 PM | Pamela EspositoDirector | Sale | 5,500 | $67.91 | $373.5K | 0(D) | View → |
| Jan 20, 2026 | Jan 20 9:29 PM | PAMELA ESPOSITO | Proposed Sale | 5,500 | $69.54 | $382.5K | — | View → |
| Dec 31, 2025 | Dec 31 10:23 PM | Nello MainolfiDirector, Chief Executive Officer | Sale | 30,000 | $78.06 | $2.3M | 663,077(D) | View → |
| Dec 31, 2025 | Dec 31 9:06 PM | Mainolfi Nello | Proposed Sale | 30,000 | $77.69 | $2.3M | — | View → |
| Dec 17, 2025 | Dec 17 9:23 PM | PAMELA ESPOSITO | Proposed Sale | 27,563 | $84.19 | $2.3M | — | View → |
| Dec 12, 2025 | Dec 12 10:20 PM | Atlas Venture Opportunity Fund I, L.P. | Proposed Sale | 108 | $89.68 | $9.7K | — | View → |
| Dec 12, 2025 | Dec 12 10:08 PM | Atlas Venture Fund X, L.P. | Proposed Sale | 570 | $89.68 | $51.1K | — | View → |
| Dec 11, 2025 | Dec 11 10:13 PM | Atlas Venture Opportunity Fund I, L.P. | Proposed Sale | 976 | $87.81 | $85.7K | — | View → |
| Dec 11, 2025 | Dec 11 10:01 PM | Atlas Venture Fund X, L.P. | Proposed Sale | 5,125 | $87.81 | $450.0K | — | View → |
| Dec 10, 2025 | Dec 10 11:39 PM | Atlas Venture Opportunity Fund I, L.P. | Proposed Sale | 36,769 | $89.89 | $3.3M | — | View → |
| Dec 10, 2025 | Dec 10 11:31 PM | Atlas Venture Fund X, L.P. | Proposed Sale | 193,040 | $89.89 | $17.4M | — | View → |
| Dec 8, 2025 | Dec 8 11:05 PM | Mainolfi Nello | Proposed Sale | 100,000 | $89.17 | $8.9M | — | View → |
| Dec 8, 2025 | Dec 8 11:03 PM | Jared Gollob | Proposed Sale | 49,307 | $66.62 | $3.3M | — | View → |
| Dec 8, 2025 | Dec 8 11:03 PM | JEFFREY ALBERS | Proposed Sale | 5,000 | $66.62 | $333.1K | — | View → |
| Oct 29, 2025 | Oct 29 8:03 PM | Mainolfi Nello | Proposed Sale | 30,000 | $61.68 | $1.9M | — | View → |
| Oct 15, 2025 | Oct 15 8:36 PM | Jared Gollob | Proposed Sale | 59,576 | $58.26 | $3.5M | — | View → |
| Oct 13, 2025 | Oct 14 11:43 AM | Jared Gollob | Proposed Sale | 3,114 | $57.21 | $178.2K | — | View → |
| Oct 13, 2025 | Oct 14 11:42 AM | JEFFREY ALBERS | Proposed Sale | 5,000 | $57.21 | $286.1K | — | View → |
| Sep 17, 2025 | Sep 17 8:24 PM | BRUCE N. JACOBS | Proposed Sale | 79,220 | $48.78 | $3.9M | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | Apr 29 9:00 PM | Nello MainolfiDirector, Chief Executive Officer | Option Exercise | 30,000 | $2.08 | 215,559(D) | View → |
| Apr 22, 2026 | Apr 24 8:33 PM | Bruce BoothDirector | Option Exercise | 5,900 | $20.00 | 39,868(D) | View → |
| Apr 22, 2026 | Apr 24 8:30 PM | Jeremy G ChadwickChief Operating Officer | Option Exercise | 300 | $43.50 | 58,263(D) | View → |
| Apr 15, 2026 | Apr 16 10:30 PM | Jeremy G ChadwickChief Operating Officer | Option Exercise | 1,300 | $43.50 | 58,463(D) | View → |
| Apr 14, 2026 | Apr 16 10:30 PM | Jeremy G ChadwickChief Operating Officer | Option Exercise | 5,251 | $43.50 | 59,763(D) | View → |
| Apr 15, 2026 | Apr 16 10:16 PM | Bruce BoothDirector | Option Exercise | 2,200 | $14.18 | 5,641(D) | View → |
| Apr 14, 2026 | Apr 16 10:16 PM | Bruce BoothDirector | Option Exercise | 4,159 | $14.18 | 7,841(D) | View → |
| Apr 9, 2026 | Apr 10 8:45 PM | Noah GoodmanChief Business Officer | Option Exercise | 2,500 | $21.05 | 97,500(D) | View → |
| Apr 1, 2026 | Apr 1 11:00 PM | Jeremy G ChadwickChief Operating Officer | Option Exercise | 14,640 | $29.64 | 68,633(D) | View → |
| Apr 1, 2026 | Apr 1 11:00 PM | Elena RidloffDirector | Option Exercise | 4,600 | $14.18 | 0(D) | View → |
| Mar 31, 2026 | Apr 1 11:00 PM | Elena RidloffDirector | Option Exercise | 7,400 | $14.18 | 4,600(D) | View → |
| Mar 31, 2026 | Apr 1 11:00 PM | Jeremy G ChadwickChief Operating Officer | Option Exercise | 7,600 | $29.64 | 83,273(D) | View → |
| Mar 25, 2026 | Mar 25 9:15 PM | Jeremy G ChadwickChief Operating Officer | Option Exercise | 24,727 | $29.64 | 90,873(D) | View → |
| Mar 23, 2026 | Mar 25 9:15 PM | Jeremy G ChadwickChief Operating Officer | Option Exercise | 84,400 | $29.64 | 115,600(D) | View → |
| Mar 20, 2026 | Mar 20 10:30 PM | Pamela EspositoDirector | Option Exercise | 2,500 | $49.10 | 0(D) | View → |
| Mar 11, 2026 | Mar 11 10:51 PM | Jeremy G ChadwickChief Operating Officer | Option Exercise | 20,000 | $43.50 | 60,548(D) | View → |
| Mar 2, 2026 | Mar 4 11:00 PM | Brian AdamsChief Legal Officer | Grant/Award | 8,250 | $90.10 | 8,250(D) | View → |
| Mar 2, 2026 | Mar 4 11:00 PM | Jeremy G ChadwickChief Operating Officer | Grant/Award | 25,150 | $90.10 | 25,150(D) | View → |
| Mar 2, 2026 | Mar 4 11:00 PM | Noah GoodmanChief Business Officer | Grant/Award | 18,450 | $90.10 | 18,450(D) | View → |
| Mar 2, 2026 | Mar 4 11:00 PM | Jared GollobChief Medical Officer | Grant/Award | 35,300 | $90.10 | 35,300(D) | View → |